UPDATE: RBC Capital Starts Verve Therapeutics (VERV) at Outperform
Tweet Send to a Friend
(Updated - February 17, 2022 4:04 PM EST)
RBC Capital analyst Luca Issi initiates coverage on Verve Therapeutics (NASDAQ ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
RBC Capital analyst Luca Issi initiates coverage on Verve Therapeutics (NASDAQ ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
